Who owns the LYTENAVA trademark?

The LYTENAVA trademark is owned by Outlook Therapeutics, Inc..

What class is the LYTENAVA trademark registered in?

The LYTENAVA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LYTENAVA?

The USPTO serial number for LYTENAVA is 98180421.

What is the registration number for LYTENAVA?

LYTENAVA is registered under USPTO registration number 0.

Sealvo

Home Search: LYTENAVALYTENAVA #98180421

Back

Updated Sep 30, 2026·39 searches this week

View on USPTO TSDR Find similar marks

LYT

USPTO Trademark Record

PENDING

LYTENAVA

SN 98180421·Reg 0·Filed Sep 14, 2023

Owner Outlook Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LYTENAVA (Serial No. 98180421), Registration No. 0, is a pending US trademark filed on Sep 14, 2023 by Outlook Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for LYTENAVA (SN 98180421) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

LYTENAVA (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 14, 2023

SERIAL

98180421

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateSep 14, 2023

Serial Number98180421

Registration No.0

Registration DateDec 31, 1969

Status DateAug 07, 2026

Published for OppositionSep 03, 2024

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1857602

480Apr 17, 2025

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 31, 2025

First use in commerce: May 31, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

31 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 08, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 07, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 3 GRANTED

Aug 07, 2026

SOU EXTENSION 3 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 07, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Apr 20, 2026

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Apr 20, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Apr 20, 2026

SOU EXTENSION 3 FILED

USE AMENDMENT FILED

Apr 20, 2026

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 15, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 FILED

Oct 14, 2025

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Oct 14, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 GRANTED

Oct 14, 2025

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 11, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 10, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Apr 10, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Apr 10, 2025

SOU EXTENSION 1 GRANTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Mar 19, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 19, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 19, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 19, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 29, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 03, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 03, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 14, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 26, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

May 14, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 14, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 14, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 08, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 03, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 18, 2023

NEW APPLICATION ENTERED

Other Marks by Outlook Therapeutics, Inc.

Additional USPTO filings from the same owner.

OUT

OUTLOOK THERAPEUTICS

88201817

OUTLOOK THERAPEUTICS, INC.

REGISTERED

LYT

LYTENAVA NAVIGATOR

97831027

Outlook Therapeutics, Inc.

PENDING

LOG

LogoMark

97831497

Outlook Therapeutics, Inc.

PENDING

LYT

LYTENAVA SPOTLYTE

97831508

Outlook Therapeutics, Inc.

PENDING

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

LYT

LYTENAVA

88872045

Outlook Therapeutics, Inc.

ABANDONED

Other Marks by Kelley B. Harrington

Additional USPTO filings handled by the same attorney of record.

SAT

SATIETY COMPLEX

99141651

REGISTERED

ROA

ROADLOK

99433132

REGISTERED

AIN

AINEKO

98040987

REGISTERED

ART

ARTIFICUM ET FABULATORES ASTERIA

98507145

REGISTERED

LYTENAVA

Run a conflict check

Other Marks by Outlook Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Kelley B. Harrington

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company